International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 414-418, May 2005

Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): Review of 10 cases

  • Bilgin Arda

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
    • Corresponding Author InformationCorresponding author.
  • ,
  • Tansu Yamazhan

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
  • ,
  • Oguz Resat Sipahi

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
  • ,
  • Sertac Islekel

      Affiliations

    • Ege University, Medical Faculty, Department of Neurosurgery, 35100 Bornova, Izmir, Turkey
  • ,
  • Çagri Buke

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
  • ,
  • Sercan Ulusoy

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey

Received 5 August 2004; accepted 17 December 2004.

Abstract 

We evaluated retrospectively, 10 MRSA meningitis cases in our hospital that occurred between January 1999 and June 2004. All were post-neurosurgical and were considered to have hospital-acquired meningitis. Fever, leukocytosis, variable conscious levels were the most common findings. Six patients were treated with regimens including teicoplanin, and four with vancomycin. Mean duration of treatment was 23.5±18.8 days (range, 3–60 days). One patient died. In cases of MRSA meningitis, intravenous vancomycin is the mainstay of therapy. However, six of these 10 patients were successfully treated with regimens including teicoplanin, suggesting that this agent may be an alternative to vancomycin in the therapy of these cases.

Keywords: Meningitis, Methicillin-resistant Staphylococcus aureus, Teicoplanin, Vancomycin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-8579(05)00049-X

doi:10.1016/j.ijantimicag.2004.12.005

International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 414-418, May 2005